Reply to 'Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients'

被引：2
|
作者：
Cattaneo, Dario [1 ]
Gervasoni, Cristina [2 ]
机构：
[1] Univ Milan, Luigi Sacco Univ Hosp, Clin Pharmacol Unit, Milan, Italy
[2] Univ Milan, Luigi Sacco Univ Hosp, Div Infect Dis 3, Milan, Italy
来源：
AIDS | 2011年 / 25卷 / 07期
关键词：
HIV-1-INFECTED PATIENTS;
D O I：
10.1097/QAD.0b013e3283463c84
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1012 / 1013
页数：2
相关论文
共 50 条
  • [21] Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen (ANRS139 TRIO Trial)
    Charpentier, Charlotte
    Fagard, Catherine
    Colin, Celine
    Katlama, Christine
    Molina, Jean-Michel
    Jacomet, Christine
    Visseaux, Benoit
    Taburet, Anne-Marie
    Brun-Vezinet, Francoise
    Chene, Genevieve
    Yazdanpanah, Yazdan
    Descamps, Diane
    PLOS ONE, 2013, 8 (01):
  • [22] Pharmacokinetics of the raltegravir/maraviroc/etravirine combination
    Calcagno, Andrea
    Nozza, Silvia
    Bonora, Stefano
    Castagna, Antonella
    de Requena, Daniel Gonzalez
    D'Avolio, Antonio
    Lazzarin, Adriano
    Di Perri, Giovanni
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) : 1932 - 1934
  • [23] Darunavir, Ritonavir, and Etravirine Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-Infected Women
    Patterson, Kristine
    Jennings, Steven
    Falcon, Ron
    Mrus, Joseph
    Kashuba, Angela
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1120 - 1122
  • [24] Pharmacokinetic Interactions of Maraviroc with Darunavir-Ritonavir, Etravirine, and Etravirine-Darunavir-Ritonavir in Healthy Volunteers: Results of Two Drug Interaction Trials
    Kakuda, Thomas N.
    Abel, Samantha
    Davis, John
    Hamlin, Julia
    Scholler-Gyure, Monika
    Mack, Rebecca
    Ndongo, Noella
    Petit, Wendy
    Ridgway, Caroline
    Sekar, Vanitha
    Tweedy, Sarah
    Hoetelmans, Richard M. W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2290 - 2296
  • [25] Reply to 'pharmacokinetic concerns related to darunavir/ritonavir plus raltegravir combination therapy trial'
    Acosta, Edward P.
    Taiwo, Babafemi
    Eron, Joseph J.
    AIDS, 2012, 26 (03) : 397 - 398
  • [26] Efficacy and Safety of Darunavir/Ritonavir Plus Etravirine Dual Regimen in Antiretroviral Therapy-Experienced Patients: A Multicenter Clinical Experience
    Gazzola, Lidia
    Cicconi, Paola
    Ripamonti, Diego
    Di Filippo, Elisa
    Gustinetti, Giulia
    Di Biagio, Antonio
    Marchetti, Giulia
    Bini, Teresa
    Monforte, Antonella d'Arminio
    HIV CLINICAL TRIALS, 2014, 15 (04): : 140 - 150
  • [27] Pharmacokinetics, Efficacy, and Safety of Darunavir/Ritonavir 800/100 mg Once-Daily in Treatment-Naive and -Experienced Patients
    Boffito, Marta
    Miralles, Diego
    Hill, Andrew
    HIV CLINICAL TRIALS, 2008, 9 (06): : 418 - 427
  • [28] Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults
    Zhang, Ying
    Joshi, Samit
    Yazdani, Parto
    Zhan, Joyce
    Wen, Bo
    Bainbridge, Veronica
    Ballesteros-Perez, Alex
    Gartland, Martin
    Lataillade, Max
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (01) : 274 - 285
  • [29] Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial
    Kakuda, Thomas
    Sekar, Vanitha
    Vis, Peter
    Coate, Bruce
    Ryan, Robert
    Anderson, David
    De La Rosa, Guy
    Mrus, Joseph
    AIDS RESEARCH AND TREATMENT, 2012, 2012
  • [30] Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants
    Moore, Katy
    Thakkar, Nilay
    Magee, Mindy
    Sevinsky, Heather
    Vakkalagadda, Blisse
    Lubin, Susan
    Llamoso, Cyril
    Ackerman, Peter
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (04)
12345